Merck and Ridgeback Biotherapeutics’ antiviral of the moment, molnupiravir, appears likely to become the first oral treatment approved for Covid-19, after interim analysis showed the pill lowered the ...
Dublin, March 08, 2023 (GLOBE NEWSWIRE) -- The "Molnupiravir Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Application (Influenza, Ebola, COVID-19, ...
SHANGHAI (Reuters) - Pfizer and Merck have slightly lowered the prices of their respective Paxlovid and molnupiravir COVID-19 treatments in China, local media reported on Tuesday citing pricing ...
Around 2,000 packages of the drug will be made available to veterinarians incrementally over the next month Author of the article: You can save this article by registering for free here. Or sign-in if ...
Inquirer Opinion on MSN
Breathless
I was having a heart attack, and the pain was so intense that I could neither breathe nor move. To make it worse, it happened during COVID-19. It was a good thing that I got to the hospital just in ...
NICOSIA, Cyprus (AP) — Cyprus’ veterinarians association on Friday lauded a government decision to allow its stock of human coronavirus medication to be used on cats to fight a local mutation of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback